Cutler Group LP Astrazeneca PLC Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	SELL	$61.89 - $69.28 $2.63 Million - $2.94 Million	-42,500 Reduced 98.84%	500 $0
Q3 2023 Nov 07, 2023	BUY	$64.85 - $71.7 $2.79 Million - $3.08 Million	43,000 New	43,000 $24,000
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $70,473 - $91,572	-1,300 Reduced 5.53%	22,200 $1,000
Q3 2022 Oct 25, 2022	SELL	$53.02 - $135.75 $281,006 - $719,475	-5,300 Reduced 18.4%	23,500 $69,000
Q2 2022 Aug 04, 2022	SELL	$59.26 - $71.14 $1.15 Million - $1.38 Million	-19,400 Reduced 40.25%	28,800 $37,000
Q1 2022 Apr 14, 2022	BUY	$55.72 - $67.12 $1.46 Million - $1.76 Million	26,200 Added 119.09%	48,200 $38,000
Q3 2021 Oct 26, 2021	BUY	$55.56 - $60.79 $222,240 - $243,160	4,000 Added 22.22%	22,000 $50,000
Q2 2021 Jul 19, 2021	BUY	$48.42 - $60.18 $871,560 - $1.08 Million	18,000 New	18,000 $35,000
Q1 2019 May 10, 2019	SELL	$35.49 - $43.02 $241,332 - $292,536	-6,800 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$32.09 - $34.78 $336,945 - $365,190	-10,500 Reduced 60.69%	6,800 $10,000
Q3 2017 Oct 17, 2017	BUY	$28.96 - $34.0 $501,008 - $588,200	17,300	17,300 $17,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.